BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7929841)

  • 1. Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.
    Marcelli M; Zoppi S; Wilson CM; Griffin JE; McPhaul MJ
    J Clin Invest; 1994 Oct; 94(4):1642-50. PubMed ID: 7929841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.
    Kazemi-Esfarjani P; Beitel LK; Trifiro M; Kaufman M; Rennie P; Sheppard P; Matusik R; Pinsky L
    Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation.
    Zoppi S; Wilson CM; Harbison MD; Griffin JE; Wilson JD; McPhaul MJ; Marcelli M
    J Clin Invest; 1993 Mar; 91(3):1105-12. PubMed ID: 8450040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular feminization associated with a thermolabile androgen receptor in culutred human fibroblasts.
    Griffin JE
    J Clin Invest; 1979 Dec; 64(6):1624-31. PubMed ID: 500829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen dependent stimulation of aromatase activity in genital skin fibroblasts from normals and patients with androgen insensitivity.
    Stillman SC; Evans BA; Hughes IA
    Clin Endocrinol (Oxf); 1991 Dec; 35(6):533-8. PubMed ID: 1769135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human complete androgen insensitivity with normal dihydrotestosterone receptor binding capacity in cultured genital skin fibroblasts: evidence for a qualitative abnormality of the receptor.
    Brown TR; Maes M; Rothwell SW; Migeon CJ
    J Clin Endocrinol Metab; 1982 Jul; 55(1):61-9. PubMed ID: 7076808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial androgen resistance due to a distinctive qualitative defect of the androgen receptor.
    Pinsky L; Kaufman M; Levitsky LL
    Am J Med Genet; 1987 Jun; 27(2):459-66. PubMed ID: 3605226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance.
    Zoppi S; Marcelli M; Deslypere JP; Griffin JE; Wilson JD; McPhaul MJ
    Mol Endocrinol; 1992 Mar; 6(3):409-15. PubMed ID: 1316540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg----Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function.
    Marcelli M; Tilley WD; Zoppi S; Griffin JE; Wilson JD; McPhaul MJ
    J Clin Endocrinol Metab; 1991 Aug; 73(2):318-25. PubMed ID: 1856263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human minimal androgen insensitivity with normal dihydrotestosterone-binding capacity in cultured genital skin fibroblasts: evidence for an androgen-selective qualitative abnormality of the receptor.
    Pinsky L; Kaufman M; Killinger DW; Burko B; Shatz D; Volpé R
    Am J Hum Genet; 1984 Sep; 36(5):965-78. PubMed ID: 6333813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced affinity of the androgen receptor for 5 alpha-dihydrotestosterone but not methyltrienolone in a form of partial androgen resistance. Studies on cultured genital skin fibroblasts.
    Pinsky L; Kaufman M; Chudley AE
    J Clin Invest; 1985 Apr; 75(4):1291-6. PubMed ID: 3872888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
    Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
    Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome.
    Tincello DG; Saunders PT; Hodgins MB; Simpson NB; Edwards CR; Hargreaves TB; Wu FC
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):497-506. PubMed ID: 9196614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding domain of the androgen receptor gene are associated with male infertility.
    Giwercman YL; Nikoshkov A; Byström B; Pousette A ; Arver S; Wedell A
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):827-34. PubMed ID: 11422119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability.
    Zhou ZX; Lane MV; Kemppainen JA; French FS; Wilson EM
    Mol Endocrinol; 1995 Feb; 9(2):208-18. PubMed ID: 7776971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome.
    Bevan CL; Hughes IA; Patterson MN
    J Steroid Biochem Mol Biol; 1997 Apr; 61(1-2):19-26. PubMed ID: 9328206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue-specific pharmacology of testosterone and 5 alpha-dihydrotestosterone analogues: characterization of a novel canine liver androgen-binding protein.
    Summerfield AE; Diaz Cruz PJ; Dolenga MP; Smith HE; Strader CD; Toney JH
    Mol Pharmacol; 1995 May; 47(5):1080-8. PubMed ID: 7746275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of nonsteroidal androgens.
    Dalton JT; Mukherjee A; Zhu Z; Kirkovsky L; Miller DD
    Biochem Biophys Res Commun; 1998 Mar; 244(1):1-4. PubMed ID: 9514878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.